Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure. [electronic resource]
Producer: 20090102Description: 178-81 p. digitalISSN:- 0145-2126
- Cell Division
- Chemokine CXCL12 -- antagonists & inhibitors
- Dipeptidyl-Peptidase IV Inhibitors
- Female
- Graft Rejection
- Hematopoietic Stem Cells -- cytology
- Humans
- Hydrolysis
- Leukemia, Myeloid, Acute -- drug therapy
- Middle Aged
- Protease Inhibitors -- pharmacology
- Pyrazines -- pharmacology
- Sitagliptin Phosphate
- Triazoles -- pharmacology
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.